Molecular Templates, Inc. announced that they will present a poster on interim clinical results for the MT-5111 program at the San Antonio Breast Cancer Symposium (SABCS) which will take place December 6 â December 10, 2022 at the Henry B. Gonzalez Convention Center in San Antonio, TX.Molecular Templates will also participate in one-on-one meetings at the 64thAmerican Society of Hematology (ASH) Annual Meeting which will take place December 10 â December 13, 2022 at the Ernest N. Morial Convention Center in New Orleans, LA. In-person and virtual meetings may be scheduled directly with Molecular Templates.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.22 USD | -.--% | -2.40% | -67.29% |
15/05 | Earnings Flash (MTEM) MOLECULAR TEMPLATES Posts Q1 Revenue $11.1M | MT |
15/05 | Molecular Templates, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-67.29% | 8.03M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- MTEM Stock
- News Molecular Templates, Inc.
- Molecular Templates, Inc. to Present Interim Results on MT-5111 at the 45th Annual San Antonio Breast Cancer Symposium and Participate at the 64th American Society of Hematology Annual Meeting